The effects of short-term, progressive exercise training on disease activity in smouldering multiple myeloma and monoclonal gammopathy of undetermined significance: a single-arm pilot study

Table 2 Compliance to prescribed exercise intensity

Prescribed intensity	Actual intensity completed	Below target (%)	Compliant (%)	Above target (%)	Participants compliant for > 75% of sessions (%)
Supervised aerobic exercise
40–50% V̇O_2PEAK	48 ± 8	0 ± 0	100 ± 50	0 ± 25	93
50–60% V̇O_2PEAK	56 ± 6	13 ± 20	86 ± 38	13 ± 14	80
60–70% V̇O_2PEAK	64 ± 4	14 ± 34	83 ± 34	0 ± 0	73
70–80% V̇O_2PEAK	70 ± 3	36 ± 53	67 ± 52	0 ± 0	40
Supervised resistance exercise
15 repetitions	15 ± 0	0 ± 0	100 ± 0	0 ± 0	100
12 rep-max	14 ± 1	100 ± 25	0 ± 50	0 ± 0	7
10 rep-max	13 ± 2	100 ± 25	0 ± 25	0 ± 0	7
8 rep-max	11 ± 3	100 ± 8	0 ± 33	0 ± 0	7
Home-based walking
RPE 12–13	11 ± 2	63 ± 67	38 ± 36	0 ± 17	13

Data are median ± IQR. Actual intensity calculated using heart rate measured by Polar H10 chest-based heart rate monitor for each session and baseline V̇O_2PEAK (supervised aerobic exercise), number of repetitions completed according to exercise record card completed by researcher (supervised resistance exercise), and RPE score reported by participants in exercise diaries (home-based walking). Compliant = within prescribed range; below target = lower intensity than prescribed range; above target = higher intensity than prescribed range. N.B. Columns do not sum to 100% due to medians calculated from data for N = 15 participants. V̇O_2PEAK = Peak oxygen uptake; Rep-max = Repetition-maximum; RPE = Rating of perceived exertion

ISSN: 1471-2407